Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 7INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Recurrent Squamous Cell Lung Carcinoma 2Melanoma 2Small Cell Lung Carcinoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Inoperable œsophageal Cancer 1Gastric and Esophagogastric Junction Adenocarcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Brain Neoplasms 1Advanced Solid Tumors 1

Interventions

pembrolizumab 1lenvatinib 1cabozantinib 1Specimen Handling 1Pluvicto 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Clear-cell metastatic renal cell carcinoma × Ipilimumab × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡